10x Genomics Joins Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas

Reuters11-18
<a href="https://laohu8.com/S/TXG">10x Genomics</a> Joins Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas

10x Genomics Inc. has announced the formation of the Asia-Pacific Spatial Translational Research Alliance (ASTRA), a consortium in partnership with the Garvan Institute of Medical Research in Australia and the University of Tokyo in Japan. This initiative aims to create a comprehensive pan-cancer spatial atlas by mapping cancer and immune cell interactions across 2,000 tumor samples using 10x Genomics' Xenium spatial platform. The consortium will expand to include additional partners across the Asia-Pacific region, establishing new research hubs and digital infrastructure to advance precision oncology and promote cross-border scientific collaboration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA26755) on November 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment